Mrinmoy Saha, [a] MichaelT .S cerba, [a] Nathaniel I. Shank, [a] Tracy L. Hartman, [b] CaitlinA.B uchholz, [b] Robert W. Buckheit,Jr. , [b] Stewart R. Durell, [c] and Daniel H. Appella* [a] Humani mmunodeficiency virus type 1( HIV-1) nucleocapsid protein 7( NCp7), az inc finger protein, plays critical roles in viral replication and maturation and is an attractive target for drug development. However,t he development of drug-like molecules that inhibit NCp7 has been as ignificant challenge.
In this study,aseries of novel 2-mercaptobenzamide prodrugs were investigated for anti-HIV activity in the context of NCp7 inactivation.T he molecules weres ynthesized from the corresponding thiosalicylic acids, andt hey are all crystalline solids and stable at room temperature. Derivatives with ar ange of amide sidec hains and aromatic substituents were synthesized and screened for anti-HIV activity.W ide ranges of antiviral activity were observed, with IC 50 values ranging from 1t o 100 mm depending on subtle changes to the substituents on the aromatic ring and side chain. Resultsf rom these structureactivity relationships were fit to ap robable mode of intracellular activation and interaction with NCp7 to explain variations in antiviral activity.O ur strategy to make as eries of mercaptobenzamide prodrugs represents ag eneral new direction to make libraries that can be screened for anti-HIV activity.
HIV continues to be am ajor publich ealth issue with approximately 37 million people affected globally. [1, 2] According to the World Health Organization, 1.1 million people died from HIV-related causes in 2015. [3] The therapies being used to manage HIV infection inhibit the essential viral enzymes reverset ranscriptase, protease,o ri ntegrase.
[4] The standard treatment for HIV is highly active antiretroviral therapy (HAART), in which combinationso fd rugs simultaneously target these viral enzymes. [5] Infectedi ndividuals who adhere to HAART can expect an ormall ife span. However,H AART requires regular and lifelonga ccess to costly medication that often impedes many HIV-infected peoplef rom receiving proper treatment. Furthermore, HAART is hampered by viral resistance [6] and may also predispose patients to cardiovascular and neurological diseases. [7, 8] Therefore, it is essential to continue the development of affordable and mutation-resistant small-molecule inhibitors of HIV.
Nucleocapsid protein 7(NCp7, Figure 1 ), a55-residue protein containing two highly conserved zinc-knuckle motifs, [9] is an attractive target for antiretroviral drugs due to its essential role in viral replication and maturation.
[10] NCp7 facilitates essential replication steps,s uch as strand transfers duringr everse transcriptiono fv iral RNA and genome packaging during virion assembly. [11] The principler ole of NCp7 is to bind viral RNA and protect it from degradation. The NCp7 protein is part of the larger HIV polyprotein Gag, whichc ontains matrix and capsid proteins.T os uccessfully mature, HIV protease must cleave peptideb onds at specific locations within Gag to liberate the matrix, capsid, and NCp7 proteins. [11] Inhibition of NCp7 yields immature virions that are noninfectious. An umber of published compounds are known to inhibit NCp7, [12, 13] and these molecules typicallyh ave electrophilic groups thatr eact with the most nucleophilic cysteine in NCp7 (shownt ob eC ys49).T hese inhibitors are also generally toxic due to nonspecific reactions with other cellular targets. In general, NCp7 has provent ob eadifficult drug target, [14] as there is no distinct three-dimensional structure for the protein other than the zinc-coordinated regions.Furthermore, traditional medicinal chemistry approaches to target the active sites of enzymesa re not applicable to ap rotein like NCp7. As ar esult, there are currently no NCp7 inhibitors that are used clinically to treat HIV infection. [15] Figure 1. Primarysequence of NCp7,with zinc-coordinating residues highlighted. The N-(blue) and C-terminal (brown) knuckles are indicated;zinc ions are represented by green spheres.
[ Our researchg roup is interested in the potentialo fm ercaptobenzamide( MB)-based molecules to inhibit HIV-1 through the inactivation of NCp7.P reviously,w eh ave shown that the S-acetyl forms of thesem olecules (MB1,F igure 2) are NCp7 inactivators that promote unfolding of the protein. [16] In contrast to other electrophilici nhibitors of NCp7, MB1 reacts selectively at Cys36 (in the C-terminal knuckle) of the protein (Figure 2 ). [17] In this mechanism, the sulfur atom of Cys36 attacks MB1 as an ucleophile at the acetyl group of the thioester.T his results in an intermolecular acetyl transfer from MB1 to the cysteine and releaseo fafree thiol (MB2). Next, an intramolecular acetyl transfer takes place between acetylatedC ys36 and aN e atom on the side chain of ap roximal lysine residue (typically Lys38). The sulfur-to-nitrogen acetyl transfer creates av ery stable amide and is likelyi rreversible. Once al ysine is acetylated, zinc coordination is disrupted,a llowing further modification of the protein and zinc ejection. As the binding of zinc is specifically required for the functiona nd stabilityo fN Cp7, loss of zinc causes disruption of the NCp7 structure, loss of function, and ultimately the formation of immature noninfectious virions.
The molecule MB2 also has the same anti-HIV activity as MB1 in cell-based assays due to au nique intracellular mechanism through which MB2 is acetylatedi nc ells by acetyl coenzyme A( CoA) to generate MB1.T he MB1 generated by activation inside cells then inactivates NCp7 by the same mechanism describedp reviously. [16, 18] Both MB1 and MB2 are too chemically unstable to developi nto drugs due to hydrolysis of the thioester and oxidation of the free thiol. In addition, these molecules display EC 50 values in the low-micromolar range in cellbased assays that test for anti-HIV activity.T esting different analogues of MB1 and MB2 could lead to the discovery of new mercaptobenzamides with better anti-HIV activity.H owever, the chemical instabilities of the thioester and thiol complicate the synthesis of analogues. Recently,w efound that the introductiono faprodrug group improves chemicals tability without compromising antiviral activity.A ttaching an S-methylbutyrate prodrug to the sulfur atom of MB2 affords MB3,w hich has exactly the same anti-HIV activity in cell-based assays. [19] The prodrug of MB3 is sensitive to esterase-promoted hydrolysis that yields butyric acid, formaldehyde, and MB2.T he toxicity of MB3 is remarkably low. [19] Attaching the S-methylbutyrate group to as eries of prodrugs facilitates the chemical synthesis of stable analogues to screen for anti-HIV activity.H erein, we report as eries of 2-mercaptobenzamidep rodrugs and their corresponding anti-HIV activity in cell-based assays. By making as eries of mercaptobenzamide prodrugs, [20] it was easier to isolate and purify analogues relative to their corresponding freet hiols or S-acetyl forms. The results from this screen allowed us to probe the influence of mercaptobenzamide substitution on anti-HIV activity,a nd how it may be rationalized by interaction with the NCp7 target.
The general synthetic route for the 2-mercaptobenzamide prodrugs is shown in Scheme 1. The mercaptobenzamides were synthesized in two steps from thiol 1.I nm ost cases,t he carboxylic acid 1 was first coupled with amine 2,u sing suitable peptide coupling reagents to form the amide bond. [21] Then, the free thiol intermediate was protected with chloromethyl butyrate (3)i nt he same pott op rovide the desired prodrug 4.T he sequence of reactions hadt ob er eversed when electron-withdrawing groupsw ere attached to the aromatic ring. The prodrugs are mostly crystalline white solids that are purified by columnc hromatography and can be stored at room temperature without any special precautions.
If the thiols were not commercially available, the precursor thiols fort he mercaptobenzamide prodrugs were synthesized in three steps (Scheme 2). [22] Amine 5 was first diazotized, and the diazo compound was treated with freshly prepared Na 2 S 2 (from Na 2 S·9 H 2 Oa nd elemental sulfur) to give disulfide 7.T he disulfideb ond in 7 was then reduced with either NaBH 4 or TCEP to produce the mercaptobenzoica cid 1. Ta ble 1l ists the anti-HIV data for 2-mercaptobenzamide prodrugs containing various functional groups on the aromatic ring. These assays use CEMSSc ellsi nfected with al aboratoryadapteds train of HIV to provide an initial gauge of anti-HIV activity relative to cellular toxicity. [19] For comparison, the activity of MB3 is listed in entry 1. Addinga ne lectron-donatingm ethoxy group (OMe, entry 2) group had little effect on the EC 50 values of anti-HIV activity and also did not influence toxicity. However,ap-hydroxy( OH, entry 3) was neither active nor toxic. Addinge lectron-withdrawing groups (entries 4-8) at the para position of the aromatic ring improves the anti-HIV activity slightly,b ut only at the expense of increasing toxicity to the cells in the assay.A na dditional electron-withdrawing group at the 4-position( entry 6) does not further improve activity.A nomethyl group to sulfur (entry 9) eliminated all anti-HIV activity, but remained nontoxic. We envisioned that the o-methyl group could obstructt he acetyl group transfer from the sulfur of the mercaptobenzamide to Cys36 of NCp7 or perhaps interfere with acetylationa ts ulfur by acetyl CoA. Therefore, we added as maller o-fluoro group to sulfur (entry 10), expecting ad ifferent result.H owever,w ef ound the o-fluoro group also has no anti-HIV activity and displays moderate toxicityt hat is consistentw ith the other derivatives with electron-withdrawing groups.
Next, we moved our attention to functionalizing the amide side chain on the 2-mercaptobenzamide prodrugs with different geminal substituents at the a-position of the amides ( Table 2 ). The anti-HIV activity of the mercaptobenzamide with a b-alanine amide side chain (MB3)i si ne ntry 1, Ta ble 1. [19] The glycinamide side chain also showed similara ctivity to MB3 (Table 2 , entry 1). Geminalb is-substitution was tolerated for an a-methylalanine amide (entry 2) and ar ing size up to 5( entries 3-5). Within this series it is interesting that the EC 50 values gradually increase as the ring size increases from at hree-, to four-, to five-membered ring. At the same time, the cellular toxicityr emains about the same within this series. Then there is ad ramatic change for the derivativew ith ar ing size of 6: this molecule hasn oa ntiviral activity and displays as ignificant increasei nc ellular toxicity (entry 7). We also briefly evaluated the anti-HIV activity of two prodrugs with the a-methylalanine amide chain and substitution on the aromatic ring (entries 7 and 8). Neithert he electron-donatingn or the electron-withdrawing group affected the EC 50 values relative to the unsubstituted form (entry 2). Cellular toxicityw as increased with the electron-withdrawing group in am anner consistent with the results in Ta ble 1. Except for the geminal cyclohexyla mide and aromatic OCF 3 groups,t he rest of the compoundsi nT able 2 are nontoxic.
The assays based on CEMSS cells were used to provide an initial gauge of antiviral activity and cellular toxicity.A tt he same time, we tested as election of compounds in an assay that more closely represents HIV infection in which human peripheral blood mononuclear cells (PBMCs) are infectedw ith ac linical isolate of HIV-1. [24] The selected compounds (MB4, MB15, MB19,a nd MB21)w ere tested in both CEMSSa nd PBMC assays, and ac omparison of data between the two assays is provided in Ta ble 3. We also included tests of am ercaptobenzamide with ap yridine ring (compound MB21). All the compounds showed no toxicity (TC 50 > 100 mm)i nP BMCs. The EC 50 values weres imilar for all the prodrugs, with only slightly weaker antiviral activity in the PMBC assay than in the CEMSSa ssay.I nterestingly, MB21,w hich has ap yridine as the core aromatic building block,s howed significantly weaker antiviral activity in the PMBC assay.
From the antiviral data, there is clearly as ubtle interplay between substituents on the aromatic ring andt he overall antiviral activity and toxicity.S ubstituents ortho to the sulfur atom effectively eliminate activity.F or instance, MB11 (which has an o-methyl group) did not have any antiviral activity or toxicity. Electron-withdrawingg roups on the aromatic ring consistently increaset he toxicity of these molecules. Based on our prior mechanistic work, the thiol of the mercaptobenzamides must be acetylated by acetyl CoA for antiviral activity (Figure 3 ). It is likely that there is ad istinct equilibrium between the free thiol MB2 and the acetylated derivative MB1 that exists within cells, mediated by the interaction of MB2 with acetyl CoA. Ap ossible explanation for the poor activity of MB11 is that the acetylation at sulfur is blockedd ue to steric hindrance from the omethyl group, and that without acetylation there is no antiviral activity.T he introductiono fe lectron-withdrawing groups on the aromatic ring maya lso interfere with acetylation by decreasingt he nucleophilicity at the sulfur atom.T his situation would perturb the equilibrium between free thiol and S-acetyl forms in favor of the free thiol, possibly increasing the general toxicity. [a] Inhibition of HIV RF in CEMSS cells was performedu sing published procedures. In eachi ndividual antivirala ssay,e fficacy and toxicity values are derived from aminimum of three replicate wells. [19] ChemMedChem 2017, 12,714 -721
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The correlation of lowered antiviral activity with increases in the steric size of side chains, as observedw ithc ompounds MB13, MB15, MB16, MB17,a nd MB18,i ndicated that there could be steric interaction with the NCp7 protein. Molecular modelsw ereg enerated to probe the interaction of this series of compoundsw ith the C-terminal finger of NCp7 (Figure 4). As described earlier,t he prodrugs are first removedb ye sterases to afford the free thiol forms of these molecules, followed by Sacetylation by acetyl CoA. For this comparison, we assumed that the S-acetyl thioester compounds 8-12 all form in the cell, and we modeled their potential to inhibitN Cp7. In the model,t he primary amide of the glycinamides ide chain of thioester 8 may form hydrogen bonds with Lys34 andHis44 of the C-terminal knuckle. At the same time the aromatic ring of 8 may engage in a p-stacking interaction with Trp37. This arrangement positions the carbonyl carbon atom of 8 forn ucleophilic attack by the sulfur atom of Cys36. Another hydrogen bonding interaction between the oxygen atom of the thioester carbonylo f 8 and Met46 may also help facilitate nucleophilic attack by increasing the electrophilicity of the carbonyl group. Asimilarmodel could also be constructed for geminal cyclopropyl (9), cyclobutyl (10), and cyclopentyl (11)g lycinamide side chains,b ut as the side chains increase in size they sterically clash with the carbonylo xygen atoms of Lys34a nd Gln45. These increases in steric hindrance between mercaptobenzamideand NCp7 may explain why the antiviral activity decreases as the size of the ring increases from 3, to 4, to 5. Am odel with compound 12 shows that the cyclohexyl group clearly cannot interact with NCp7 in the same manner as the previous compounds, as the ring sterically clashes with Lys34, Gln45, andH is44. This steric interaction probably eliminates the antivirala ctivity of compound 12 in the cell-based assays.
In conclusion, as eries of novel 2-mercaptobenzamide prodrugs was synthesized and evaluated for their antiviral activity.C ell viability studies in the same cell line indicate that most of these molecules are nontoxic (TC 50 > 100 mm). These prodrugs are stable at room temperature, crystalline, and easily synthesized in two steps from [a] Inhibitiono fH IV RF in CEMSS cells and inhibition HIV-1 92HT599 in humanP BMCs was performed using previously published procedures. In each individual antiviral assay,efficacy and toxicity valuesare derived from am inimumo ft hree replicate wells. [19] ChemMedChem 2017, 12,714 -721
www.chemmedchem.org the corresponding aromatic substituted thiols. The substituted thiols were synthesized from inexpensive starting materials. We speculate that ortho substitution next to the sulfur atom may hinder acetylation of the thiol by acetyl CoA. It is possible that electron-withdrawing groups decrease the nucleophilicity of the sulfur atom and lead to alternative modes of reactivity that are toxic. We found that the introduction of geminal disubstitution on the amide side chain may be tolerated to an extent,b ut large rings like cyclohexyl likely block interaction with NCp7. Further improvementa nd applicationso ft he mercaptobenzamide prodrugs will continue.
Experimental Section
1 HNMR spectra were recorded in deuterated solvents and are reported in ppm relative to tetramethylsilane and referenced internally to the residually protonated solvent.
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CNMR spectra were recorded in deuterated solvents and are reported in ppm relative to tetramethylsilane and referenced internally to the residually protonated solvent. Routine monitoring of reactions was performed using EM Science DC-Alufolien silica gel TLC plates. Flash chromatography was performed with the indicated eluents on EM Science Gedurian 230-400 mesh silica gel. Air-and/or moisture-sensitive reactions were performed under usual inert atmosphere conditions. Reactions requiring anhydrous conditions were performed under ab lanket of nitrogen, in glassware dried in an oven at 130 8Co rb y flame, then cooled under nitrogen. Dry acetonitrile, DMF,T HF,a nd CH 2 Cl 2 were obtained via as olvent purification system. All other solvents and commercially available reagents were either purified via published procedures or used without further purification.
General procedure for the synthesis of prodrugs 4: Method A:
To as tirred solution of thiosalicylic acid 1 in DMF (0.2 m)a tR Twas added HBTU or HATU or HCTU (1 equiv) and iPr 2 NEt (3.5 equiv) sequentially.A fter 10 min, the amine 2 (1.05 equiv) was added to the previous solution. After stirring for 16-24 h, chloromethyl butyrate 3 (0.99 equiv) was added to the reaction mixture and stirred for 12-18 h. Then, the reaction was concentrated in vacuo and treated with H 2 O. The aqueous layer was extracted with EtOAc (3 )a nd the combined organic layer was washed with 1 m HCl (2 ), saturated NaHCO 3 (2 )a nd brine. The dried (Na 2 SO 4 )e xtract was then concentrated in vacuo, and the crude product was purified by chromatography over silica gel, eluting with EtOAc/hexanes or MeOH/EtOAc or MeOH/CH 2 Cl 2 ,tog ive 4.
Method B:T oastirred solution of thiosalicylic acid 1 in DMF (0.2 m)a tR Twas added iPr 2 NEt (2.5 equiv) and chloromethyl butyrate 3 (0.99 equiv). After stirring for 18-24 h, HBTU or HATU or HCTU (1 equiv), amine 2 (1.05 equiv) and iPr 2 NEt (1 equiv) were added to the previous solution sequentially and stirred for 16-24 h. Then, the reaction was concentrated in vacuo and treated with H 2 O. The aqueous layer was extracted with EtOAc (3 )a nd the combined organic layer was washed with 1 m HCl (2 ), saturated NaHCO 3 (2 )a nd brine. The dried (Na 2 SO 4 )e xtract was then concentrated in vacuo and the crude product was purified by chromatography over silica gel, eluting with EtOAc/hexanes or MeOH/ EtOAc or MeOH/CH 2 and treated with as olution of sodium hydroxide (900 mg, 22.5 mmol) in 7.5 mL H 2 O. The mix was stirred for an additional 5min before being used in the next step. The freshly prepared disodium disulfide (Na 2 S 2 )s olution was poured into al arge Erlenmeyer flask maintained at % 0 8Cv ia an external ice water bath. A handful of ice chips were added, and ab last shield placed in front of the flask. Using the utmost caution, the cooled (0 8C) diazonium solution was carefully and slowly poured into the cooled (0 8C) solution of Na 2 S 2 and the reaction was allowed to stir at 08 to RT overnight. The reaction was then acidified to % pH 1w ith concentrated HCl, and the resulting precipitate was filtered and washed thoroughly with cold water.T he solids were then transferred to an Erlenmeyer flask, combined with saturated aqueous potassium carbonate and heated gently to produce ah eterogeneous mixture of dark-brown liquor (basic to pH paper) and cream-colored solids. The mixture was passed through ap ad of Celite, and the filtrate was carefully acidified to % pH 1w ith drops of concentrated HCl. The resulting precipitate was isolated by filtration, washed with cold water and dried in vacuo to give 7 of ac rude tan solid that was carried forward to the next step without further purification.
General procedure for the syntheses of thiols:M ethod A:D isulfide 2 was suspended in MeOH (0.1 m)u nder N 2 atmosphere at RT and sodium borohydride (4 equiv) was added in small portions over the course of 30 min. Then, the reaction mixture was stirred for 2-12 ha nd the yellow slurry became ac lear solution during the reaction. The reaction was carefully quenched with drops of water and the solvents were removed under reduced pressure. The residue was combined with water and acidified to pH % 1w ith drops of concentrated HCl to give ap ale-yellow precipitate. The precipitate was filtered, washed with ice-cold water (5 )a nd dried on aB üchner funnel overnight under nitrogen atmosphere to give 1 as ac rude yellowish white solid that was used immediately in the next step.
General procedure for the syntheses of thiols:Method B:T oasolution of disulfide 2 in 9:1D MF/H 2 O( 0.1 m)w as added TCEP hydrochloride (1.5 equiv) and Et 3 N( 3equiv) at RT.A fter stirring for 18 h, the reaction was concentrated in vacuo at 45 8Ca nd treated with cold water.T he mixture was stirred vigorously for 2hand acidified (pH % 1) with concentrated HCl to give yellow precipitate. The precipitate was filtered, washed with ice-cold water (5 )a nd dried on aB üchner funnel overnight under nitrogen atmosphere to give 1 as ac rude yellowish white solid that was used immediately in the next step.
MB7:T oas tirred solution of thiophenol SI-7 (54 mg, 0.206 mmol) in DMF (0.25 mL) at RT was added triethylamine (57 mL, 0.309 mmol). After 3min, chloromethyl butyrate 3 (40 mL, 0.309 mmol) was added and the mixture was stirred for 18 h. The reaction was quenched with 5mLH 2 Oa nd extracted with EtOAc (3 10 mL). The combined organic layers were washed with brine, dried (Na 2 SO 4 )a nd concentrated in vacuo. The resulting residue was purified by silica gel chromatography (EtOAc/hexanes) to give MB7 (24 mg, 34 %y ield) as al ight-tan solid. Anti-HIV cytoprotection evaluation-assay methodology:I nhibition of virus-induced cytopathic effects (CPE) and cell viability following HIV replication in CEM-SS cells was measured by XTT tetrazolium dye. CEM-SS cells (2.5 10 3 cells per well) were seeded in 96-well U-bottomed tissue culture plates in RPMI medium supplemented with 10 %F BS, 2mml -glutamine, 100 UmL À1 penicillin and 100 mgmL À1 streptomycin. Serially diluted compounds (six concentrations) and HIV-1 RF diluted to ap re-determined titer to yield 85-95 %c ell killing at six days post-infection were be added to the plate. AZT was evaluated in parallel as ap ositive control. Following incubation at 37 8C, 5% CO 2 for six days, cell viability was measured by XTT staining. The optical density of the cell culture plate was determined spectrophotometrically at 450 and 650 nm using Softmax Pro 4.6 software. Percent CPE reduction of the virus-infected wells and the percent cell viability of uninfected drug control wells were calculated to define the EC 50 ,T C 50 and therapeutic index (TI 50 )using Microsoft Excel Xlfit4.
Anti-HIV evaluation in human PBMCs-assay methodology: PHA-P stimulated PBMCs from three donors were pooled together and resuspended in fresh tissue culture medium 1 10 6 cells per mL and plated in the interior wells of a9 6-well round-bottom microplate at 50 mLp er well. A1 00 mLv olume of nine concentrations of compound serially diluted were transferred to the roundbottom 96-well plate containing the cells in triplicate;5 0mLo fHIV1a tapre-determined dilution was added. Each plate contained cell control wells and virus control wells in parallel with experimental wells. After seven days in culture, efficacy was evaluated by measuring the reverse transcriptase in the culture supernatants ChemMedChem 2017, 12,714 -721 www.chemmedchem.org 2017 Wiley-VCH Verlag GmbH &Co. KGaA, Weinheim and the cells were stained with the tetrazolium dye XTT to evaluate cytotoxicity.
General method for docking:M odels of the different inhibitor compounds were developed with the CHARMM software package. [25] The structure of the C-terminal finger of NCp7 was obtained from the NMR-derived ensemble determined by Lee et al. (PDB ID:  1MFS) . [26] Images of the "manually" docked complexes were developed with the UCSF Chimera software program. [27] 本文献由"学霸图书馆-文献云下载"收集自网络，仅供学习交流使用。 学霸图书馆（www.xuebalib.com）是一个"整合众多图书馆数据库资源， 提供一站式文献检索和下载服务"的24 小时在线不限IP 图书馆。 图书馆致力于便利、促进学习与科研，提供最强文献下载服务。 图书馆导航： 图书馆首页 文献云下载 图书馆入口 外文数据库大全 疑难文献辅助工具
